High Variation of Intravitreal Injection Rates and Medicare Anti-Vascular Endothelial Growth Factor Payments per Injection in the United States

Medicine & Life Sciences

• Intravitreal Injections 100%
• Medicare 87%
• Vascular Endothelial Growth Factor A 72%
• Fee-for-Service Plans 49%
• Injections 48%
• Medicare Part B 24%
• Current Procedural Terminology 21%
• Pharmaceutical Preparations 19%
• Centers for Medicare and Medicaid Services (U.S.) 9%
• Drug Costs 9%
• Ophthalmology 8%
• Observational Studies 5%
• Cohort Studies 5%
• Health Care Outcome Assessment 5%
• Databases 4%
• Therapeutics 1%